International Stem Cell Corporation (ISCO)
OTCMKTS
· Delayed Price · Currency is USD
0.0800
+0.0200 (40.00%)
Oct 22, 2024, 3:44 PM EDT
International Stem Cell Revenue
International Stem Cell had revenue of $2.33M in the quarter ending June 30, 2024, with 26.62% growth. This brings the company's revenue in the last twelve months to $8.32M, up 3.25% year-over-year. In the year 2023, International Stem Cell had annual revenue of $7.79M, down -4.78%.
Revenue (ttm)
8.32M
Revenue Growth
+3.25%
P/S Ratio
0.07
Revenue / Employee
286.97K
Employees
29
Market Cap
560.31K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.79M | -391.00K | -4.78% |
Dec 31, 2022 | 8.18M | 1.00M | 13.99% |
Dec 31, 2021 | 7.18M | 48.00K | 0.67% |
Dec 31, 2020 | 7.13M | -2.34M | -24.75% |
Dec 31, 2019 | 9.47M | -1.62M | -14.58% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 920.97M |
Vireo Growth Inc. | 98.04M |
Medexus Pharmaceuticals Inc. | 108.78M |